Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
B cell receptor associated protein 31 pseudogene 2 (BCAP31P2) is a pseudogene, meaning it is a nonfunctional genomic DNA segment that closely resembles the coding sequence of the functional gene B cell receptor associated protein 31 (BCAP31) but does not produce a functional protein[4][8][9][10]. Pseudogenes may arise from gene duplication or retrotransposition events, and can sometimes influence gene expression or be involved in genetic diseases through processes such as gene conversion or serving as competing endogenous RNAs[1][3][5][9]. However, there is no evidence that BCAP31P2 itself encodes a functional protein, nor is it considered a therapeutic target. Its primary relevance is for genomic annotation rather than direct biological or therapeutic function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on B cell receptor associated protein 31 pseudogene 2 (BCAP31P2).